ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Program Announcement Completes NCI switch To Control Research

April 16, 1982

Funding Opportunities.

March 15, 2002

Tobacco Council Announces 12 New Awards, Six Relating To Smoking

August 2, 1974

In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans

February 24, 1984

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001